Cyclosporine a inhibits lymphocyte migration into ovine peripheral nerve allografts

Microsurgery

Volumn 17, Issue 12, 1996, Pages 697-705

  Hare, Gregory M T ^a   Mackinnon, Susan E ^b,d   Midha, Rajiv ^c   Wong, Pui Yeun ^e   Au, Bihn ^c   Munro, Catherine ^c   Andrade, William ^c   Hunter, Daniel A ^b   Hay, John B ^c  

^a DALHOUSIE UNIVERSITY   (Canada)

^b BARNES JEWISH HOSPITAL   (United States)

^c UNIVERSITY OF TORONTO   (Canada)

^d WUMC   (United States)

^e NONE

Author keywords

[No Author keywords available]

Indexed keywords

8 QUINOLINOL INDIUM IN 111; BCG VACCINE; CYCLOSPORIN A; DRUG VEHICLE; EVANS BLUE; OLIVE OIL; SODIUM CHLORIDE; TUBERCULIN;

ALLOGRAFT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOGRAFT; CELL LABELING; CONTROLLED STUDY; DELAYED HYPERSENSITIVITY; DRUG BLOOD LEVEL; GRAFT REJECTION; IMMUNOSUPPRESSIVE TREATMENT; INTRADERMAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; ISOTOPE LABELING; LYMPHOCYTE COUNT; LYMPHOCYTE MIGRATION; NERVE GRAFT; NONHUMAN; PRIORITY JOURNAL; RADIOIMMUNOASSAY; SHEEP; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0031432244     PISSN: 07381085     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2752(1996)17:12<697::AID-MICR7>3.0.CO;2-K     Document Type: Article

References (37)

1. Mackinnon SE, Hudson AR: Clinical application of peripheral nerve transplantation. Plast Reconstr Surg 90:695-699, 1992.
2. Mackinnon SE: Nerve allotransplantation following severe tibial nerve injury. J Neurosurg 84:671-676, 1996.
3. Bain JR, Mackinnon SE, Hudson AR, Falk RE, Falk JA, Hunter DA: The peripheral nerve allograft: An assessment of regeneration across nerve allografts in rats immunosuppressed with cyclosporin A. Plast Reconstr Surg 82:1052-1064, 1988.
4. Yu LT, England J, Sumner A, Larossa D, Hickey WF: Electrophysiological evaluation of peripheral nerve regeneration through allografts immunosuppressed with cyclosporin. J Reconstr Microsurg 6:317-323, 1990.
5. Gulati AK: Evaluation of acellular and cellular nerve grafts in repair of rat peripheral nerve. J Neurosurg 68:117-123, 1988.
6. Zalewski AA, Gulati AK: Survival of nerve allografts in sensitized rats treated with cyclosporin A. J Neurosurg 60:828-834, 1984.
7. Ide C, Osawa T, Tohyama K: Nerve regeneration through allogenic nerve grafts, with special reference to the role of the Schwann cell basal lamina. Prog Neurobiol 34:1-38, 1990.
8. Mackinnon SE, Hudson AR, Falk RE, Kline D, Hunter D: Peripheral nerve allograft: An immunological assessment of pretreatment methods. Neurosurgery 14:167-171, 1984.
9. Zalewski AA, Gulati AK: Evaluation of histocompatibility as a factor in the repair of nerve with a frozen nerve allograft. J Neurosurg 56: 550-554, 1982.
10. Hare GMT, Evans PJ, Mackinnon SE, Nakao Y, Midha R, Wade JA, Hunter DA, Hay JB: Effect of cold preservation on lymphocyte migration into peripheral nerve allografts in sheep. Transplantation 56: 154-162, 1993.
11. Hare GMT, Evans PJ, Mackinnon SE, Wade JA, Young AJ, Hay JB: Phenotypic analysis of migrant, efferent lymphocytes after implantation of cold preserved, peripheral nerve allografts. J Neuroimmunol 56:9-16, 1995.
12. Strasberg SR, Mackinnon SE, Hare GMT, Narini PP, Hertl MC, Hay JB: Reduction in peripheral nerve allograft antigenicity with warm and cold temperature preservation. Plast Reconstr Surg 97:152-160, 1996.
13. Strasberg SR, Mackinnon SE, Genden EM, Bain JR, Purcell CM, Hunter DA, Hay JB: Long-segment nerve allograft regeneration in the sheep model: Experimental study and review of the literature. J Reconstr Microsurg 12:529-537, 1996.
14. Midha R, Mackinnon SE, Evans PJ, Best TJ, Hare GMT, Hunter DA, Falk-Wade JA: Comparison of regeneration across nerve allografts with temporary or continuous cyclosporin A immunosuppression. J Neurosurg 78:90-100, 1993.
15. Bain JR, Mackinnon SE, Hudson AR, Wade JA, Evans PJ, Mikino AP, Hunter DA: The peripheral nerve allograft in the primate immunosuppressed with cyclosporin A: I. Histologic and electrophysiologic assessment. Plast Reconstr Surg 90:1036-1046, 1992.
16. Mackay CR: Summary of workshop findings for leukocyte antigens of sheep. Vet Immunol Immunopathol 27:28-32, 1991.
17. Borgs P, Hay JB: A quantitative lymphocyte localization assay. J Leukocyte Biol 39:333-342, 1986.
18. Charles BG, Filippich LJ, Pass MA: Pharmacokinetics and absolute bioavailability of cyclosporin following intravenous and abomasal administration to sheep. J Pharm Pharmacol 45:821-824, 1993.
19. Treshman JA, Whitworth JA, Scoggins BA, Bennett WM: The failure of nisodipine to prevent the hypertensive response to cyclosporin A infusion in sheep. J Hypertens 8:1007-1013, 1990.
20. Tresham JA, Whitworth JA, Scoggins BA, Bennett WM. Cyclosporine-induced hypertension in sheep. The role of thromboxanes. Transplantation 49:144-148, 1990.
21. Midha R, Mackinnon SE, Wade JA, Evans PJ, Best TJ, Wong PY: Chronic cyclosporine A therapy in rats. Microsurgery 13:273-276, 1992.
22. Midha R, Mackinnon SE, Evans PJ, Best TJ, Wong PY: Subcutaneous injection of oral cyclosporin A solution. Microsurgery 13:92-94, 1992.
23. Peracchia C, Mittler BS: Fixation by means of gluteraldehydehydrogen peroxide reaction products. J Cell Biol 53:234-238, 1972.
24. 125I-Incstar assays. Transplant Proc 2:1166-1170, 1990.
25. Dunnett CW: A multiple comparison procedure for comparing several treatments with a control. J Am Star Assoc 50:1096-1103, 1953.
26. Winer BJ: Statistical Principles in Experimental Design (2nd ed). London, McGraw-Hill, 1971.
27. Kahan BD: Cyclosporine. N Engl J Med 321:1725-1738, 1989.
28. The Canadian Multicentre Transplant Study Group: A randomized clinical trial of cyclosporine in cadaveric renal transplantation: Analysis at three years. N Engl J Med 314:1219-1225, 1986.
29. Oyer PE, Stinson EB, Jamieson SW, Hunt SA, Perlroth M, Billingham M, Shumway NE: Cyclosporine in cardiac transplantation: A 2 1/2 year follow-up. Transplant Proc 15:2546-2552, 1983.
30. Starzl TE, Klintmalm GBG, Porter KA, Iwatsuki S, Schroter GPJ: Liver transplantation with use of cyclosporin A and prednisone. N Engl J Med 305:266-269, 1981.
31. Feutren G, Papoz L, Assan R, Vialettes B, Karstenv G, Vexiau P, Du-Rostu H, Rodier M, Sirmai J, Lallamand A, Back JF: Cyclosporin increases the rate and length of remissions in insulin-dependent diabetes of recent onset: Results of a multicentre double-blind trial. Lancet 2:119-124, 1986.
32. Zachariae H, Steen-Olsen T: Efficacy of cyclosporin A (CyA) in psoriasis: An overview of dose/response, indications, contraindications and side-effects. Clin Nephrol 43:154-158, 1995.
33. Flipo RM, Reigneau O: The benefit/risk ratio of low dose cyclosporin A in rheumatoid arthritis. J Rheumatol 23:404-405, 1996.
34. Korelitz BI: Immunosuppressive therapy of inflamatory bowel disease: A historical perspective. Gastroenterologist 3:141-152, 1995.
35. Wassef R, Cohen Z, Langer B: Pharmacokinetic profiles of cyclosporine in rats. Influence of route of administration and dosage. Transplantation 40:489-493, 1985.
36. Batiuk TD, Urmson J, Vincent D, Yatscoff RW, Halloran PF: Quantitating immunosuppression. Estimating the 50% inhibitory concentration for in vivo cyclosporine in mice. Transplantation 61:1618-1624, 1996.
37. Webster LM, Thomson AW: Cyclosporine A prevents suppression of delayed-type hypersensitivity in mice immunized with high-dose sheep erythrocytes. Immunology 60:409-415, 1987.